@article{APM1327,
author = {Yang Ling},
title = {Breakthrough expected in translational research of targeted therapy for small cell lung cancer},
journal = {Annals of Palliative Medicine},
volume = {1},
number = {3},
year = {2013},
keywords = {},
abstract = {Small cell lung cancer (SCLC) accounted for 12-15% of the 213,380 lung cancer cases and 160,390 deaths newly reported in the U.S. in 2010 (1). SCLC is a highly aggressive disease characterized by rapid multiplication, high growth fractions, early dissemination and metastasis, and high sensitivity to first-line chemotherapy and radiotherapy. About 60-70% of the patients are not diagnosed until extensive-stage disease (ED) (2).},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/1327}
}